About UsFacultyResearchSeminarsGraduatePost-DoctoralUAB

 

Faculty Directory

 

Faculty Research

 

Grants and Awards

 

Faculty Resources

 

Program Home

 

FEATURES

Special Funding Opportunities and Requests for Information

Funding Opportunities and Useful Links

Immunology Bloglines

Grants.gov and Other Useful Links for Electronic Grant Submission

Recent Grant News from the NIH

 


Special Funding Opportunities (updated October 25, 2007)

 

American Association of Immunologists/Experimental Biology 2008

 

The 95th annual AAI/Experimental Biology meeting will take place in San Diego, CA, April 5-9, 2008. The abstract submission deadline is November 7, 2007. For more information, please see: http://www.aai.org/2008Meeting/Program.htm To submit an abstract, see: http://www.eb2008.org/AbstractSubmission.htm

American Association of Immunologists Travel and Career Awards

Deadline: November 14, 2007.

Nominations are solicited for several career awards that will sponsor travel to the annual meeting. A request for applications for travel awards has also been posted. The AAI Annual Meeting will be held in conjunction with the Experimental Biology meeting in San Diego, CA, April 5-9, 2008.
 


Osteoimmunology-Crosstalk between Immune System and Bone

R01: RFA-DE-08-006 / R21: RFA-DE-08-007

Letter of Intent due December 14, 2007; Application Deadline: January 14, 2008

 

This funding source seeks to support novel research projects designed to provide a fundamental understanding of the intersystem crosstalk between alveolar bone and the immune system, and how osteoimmunology operates in normal and pathologic conditions.

 


Arthritis National Research Foundation Grants
Deadline: January 16, 2008.
Guidelines and Policies
 

The Arthritis National Research Foundation (ANRF) is dedicated to funding highly qualified investigators associated with major research institutes, universities and hospitals throughout the country who are seeking to discover new knowledge for the prevention, treatment and cure of arthritis and other rheumatic diseases. The group has recently announced that the maximum funding level for grants has increased to $75,000 to fund salaries, supplies, and equipment related to the project. Between 8-15 grants are funded annually. Preference is given to senior post-doctoral investigators transitioning to independent investigator status and new assistant professors.
 


Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases
R21: PAR-07-446 / R03: PAR-07-447
Letter of Intent Due October 20, 2007; Application Deadline: November 20, 2007.

This funding opportunity announcement (FOA) is to support innovative exploratory/developmental studies of primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models. A secondary objective is to stimulate research by bringing investigators new to primary immunodeficiency diseases research into the field.
 


Medical Biological Defense Research Program
Continuously open announcement.


The Medical Biological Defense Research program, sponsored by the DOD, et al., provides medical counter-measures for biological warfare agents. These studies include Viral, Toxin, Bacterial Studies, and relevant Drug Development (e.g., identification and characterization of organisms and toxins; molecular antigenic analysis; development of diagnostic assays; studies on structure and function that are related to mechanism of action, binding, internalization and interaction with the immune system and neutralizing antibodies; investigation of pathogenesis and immunology that will allow decision regarding the optimal approach to disease prevention and control).

 


Functional Links between the Immune System, Brain Function and Behavior

R01: PA-07-088

Deadline: February 5, 2008

 

This Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH), the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Drug Abuse (NIDA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institute on Neurological Disorders and Stroke (NINDS), and the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits research grant applications to study neuroimmune molecules and mechanisms involved in regulating normal and pathological central nervous system (CNS) function.
 


 

Funding Opportunities and Useful Links

Agency for Healthcare Research and Quality (AHRQ) funding opportunities

Centers for Disease Control (CDC) funding

Community of Science

Department of Defense funding opportunities for medical research

Department of Education (ED) grants and contracts

National Endowment for the Arts grants page

National Endowment for the Humanities (NEH) grants page

National Science Foundation (NSF)

U.S. Department of Agriculture (USDA) research opportunities

Weekly NIH funding opportunities

 


 

Immunology Bloglines

 

Bloglines is a window to a whole new world of dynamic content that is being created and distributed over the new "live" web.

Immunology Bloglines has been tailored to the interests of its constituency, including the latest grant and contract information from the NIH as well as the most recent tables of contents from high impact journals such as Cell, Science, and Nature.

 

Click here to access Immunology Bloglines.
 


Grant submission to all governmental agencies will soon require complete electronic transmission.  To aid in this transition, grants.gov has been organized to facilitate the application process. 

 

Applicants will be required to download and use the PureEdge Viewer (for PC users) or the MAC Supported PureEdge Viewer (for Mac users).

Training Demonstrations are available to help adjust to this new process:

Complete Application Package Training Demo

Submit Application Tips

Application Error Tips

Convert Documents to PDF

 

NIH eRA Commons

Electronic Research Administration (eRA) is a core service of the Office of Electronic Research and Reports Management (OERRM) in the NIH Office of the Director. OERRM's eRA information technology program provides grants administration support to NIH institutes and centers and to all Department of Health and Human Services (DHHS) agencies that fund extramural research.

 

Other Useful Links for Electronic Grant Submission

Annual eRA Symposium Grants.gov: FIND & APPLY

NIH Transition to the SF424 (R&R)

Grants.gov Forms Repository

NIH eRA Website

SF424 (R&R) Application and Electronic Submission Information
Includes a document providing a sample Table of Contents & a chart cross-referencing the location in the forms components for each piece of the grant image.

NIH Electronic Submission of Grant Applications

Grants.gov Help Desk
Grants.gov customer support
Contact Center Phone: 1-800-518-472
Business Hours M-F 7 a.m.-9 p.m. Eastern Standard Time
Email: support@grants.gov

eRA Commons Help Desk
Phone: 301-402-7469 / 866-504-9552 (Toll Free)
301-451-5939 (TTY)
Business hours M-F 7am-8pm Eastern Standard Time
Email: commons@od.nih.gov
Grants Information
Phone: 301-435-0714
301-451-0088 (TTY)
Email: GrantsInfo@nih.gov
 


Recent Grant News from the NIH
(updated October 9, 2006)

NIH Extramural NEXUS


FEATURES

Change in 2007 NIH Grant Deadlines

R03, R21, R33, and R34 Grant Mechanisms: Transition to Electronic Submission

The NIH Published Salary Limitation on Grants, Cooperative Agreements, and Contracts

NIH Fiscal Operations Plan for FY 2006

Electronic Grant Submission to the NIH

The NIH Launches Multiple Principal Investigator Initiative

 

Change in 2007 NIH Grant Deadlines: To accommodate the anticipated large volume submissions, the NIH has staggered several standing grant deadlines.  For a calendar, click here.    To be considered "On Time", a grant must be received by Grants.gov NO LATER THAN 5pm, local time.

 

Please click here for more information.

 

R03, R21, R33, and R34 Grant Mechanisms: Transition to Electronic SubmissionThe purpose of this Notice is to announce the following changes regarding funding opportunity announcements (FOAs) that utilize the Small Research Grant (R03), Exploratory/Developmental Research Grant (R21), the Phased Innovation Award (R21/R33), and the NIH Clinical Trial Planning Grant (R34) mechanisms.  Effective June 1, 2006, R03 and R21 paper applications will no longer be accepted by the NIH, AHRQ or CDC.

 

Please click here for more information.

The NIH Published Salary Limitation on Grants, Cooperative Agreements, and Contracts—This notice provides updated information regarding the salary limitation for NIH grant and cooperative agreement awards and extramural research and development contract awards. On January 7, 2005 the Fiscal Year (FY) 2005 information on the salary limitation was published in the NIH Guide for Grants and Contracts. (NOT-OD-06-031)

Please click here for more information.


NIH Fiscal Operations Plan for FY 2006 (by Norka Ruiz Bravo, PhD - Director, OER and NIH Deputy Director for Extramural Research)—As many of you know, the President signed the Department of Health and Human Services appropriations bill on December 30, 2005. The NIH appropriation included a 1 percent across-the-board cut for all non-emergency discretionary programs; the NIH share is $286 million. This has forced NIH to make some very tough choices. Paramount in making these choices is two principles: we must continue to support the very best biomedical research in the world; and we must ensure that the next generation of scientists continues to have the opportunity to compete successfully for grants and transition to independent investigator status.

Guided by these principles, NIH will reduce all non-competing research project grant (RPG) awards by 2.35 percent; restore funds to all previously issued FY 2006 awards to 97.65 percent of the amount indicated in the FY 2005 Notice of Grant Award; and maintain the average cost of competing RPGs at FY 2005 levels. By undertaking these difficult measures, we expect to achieve an overall success rate of approximately 19.5 percent compared to 22.3 percent in FY 2005. We also expect to fund more than 38,300 competing and non-competing RPGs. When compared to FY 2005, this represents a decrease of about 570 RPGs or 1.5 percent.

As difficult as these decreases will be to absorb, by tightening our belts in this fashion, we will be able to continue to fund the very best biomedical research in the world. We remain concerned, however, about the impact of falling success rates on the next generation of investigators. Therefore, we expect to announce programs targeting new investigators soon.

Please click here for more information on the NIH Fiscal Operations Plan


Electronic Grant Submission to the NIH (from ExtramuralNexus)—As it continues to transition grant programs to electronic submission, the NIH is now preparing for the October 1, 2006 changeover of its largest grant program, the R01 or Research Project Grant Program, which has been known to receive 10,000 applications for a single receipt cycle.

Having received a great deal of feedback from applicants that took part in the initial submissions, NIH offers the following advice to applicants:

  • Be informed. For up-to-date, general information on electronic submission, the SF424 (R&R), and Service Providers, visit the NIH Electronic Submission of Grant Applications Web site.

  • Follow all instructions carefully. Information found in the funding opportunity announcement and the application guide that accompanies each application package is critical to submitting a complete and accurate application to NIH. Many applicants spent a great deal of time correcting errors and resubmitting applications. Much of this effort can be avoided by reading and following the instructions up-front. Sample versions of the application guide and packages are available, as are the most common application errors.

  • Be prepared, register early. One-time registrations for both Grants.gov and eRA Commons systems must be completed before application submission. These are two distinct systems with separate registration requirements.

Registration Tips:

  • The registration process can take several weeks, especially when close to submission dates when registration volume peaks. Start early to avoid delays! NIH recommends starting the registration process now, or at a minimum two-four weeks ahead of your target submission date. New organizations may need to start the Grants.gov registration process even earlier to obtain the necessary DUNS numbers and CCR registrations required for Grants.gov registration.

  • Applicant organizations must register both in Grants.gov and eRA Commons, but Principal Investigators (PIs) need only register in eRA Commons.

  • The PI must hold a PI account and be affiliated with the applicant organization in the eRA Commons.

  • Both the Principal Investigator (PI) and Signing Official (SO) need separate accounts in eRA Commons since both need to verify the application. If you are the SO for your organization as well as a PI of the grant, you will need two separate accounts with different user names - one with SO authority and one with PI authority.

  • Organizations must include the DUNS number in their eRA Commons profile that matches the DUNS number to be used on the submitted applications.

Grants.gov and eRA Commons registration processes may be done concurrently.


The NIH Launches Multiple Principal Investigator Initiative (from ExtramuralNexus)—As scientific problems have become more complex, so have the ways that we must address them. Many scientists are moving from reductionist to systems approaches, and biomedical science increasingly involves teams of investigators, who have been trained in different disciplines. NIH recognized the importance of interdisciplinary approaches and team science by launching a comprehensive Roadmap initiative designed specifically to encourage this kind of research.

There are, however, systemic barriers to team research. These barriers include the fact that NIH recognizes only a single Principal Investigator (PI) on research grants. That means that frequently, major contributors to NIH-funded research projects do not receive appropriate credit for their intellectual contributions, and this serves as a deterrent to team science. The NIH along with the Office of Science and Technology Policy recently issued Requests for Information (RFIs) in order to gauge the level of support within the scientific community for the overall multiple-PI concept. Responses revealed overall support for the multiple-PI initiative, as well as for the idea of budget allocation to individual PIs and the development of ways to use linked awards to support projects that span more than one institution. To reduce this barrier and encourage and facilitate a broader use of team approaches, the NIH plans to start recognizing more than one PI on research grants and contracts.

Beginning in May 2006, the NIH expects to start receiving applications that name more than one PI. Initially, this capacity will be restricted to a small number of pre-announced Requests for Applications (RFAs) and Program Announcements (PAs). A phased approach will allow us to test this very complex adaptation of our administrative systems in order to ensure that everything is working correctly before we open it up to all applicants. A timeline for the complete roll-out will be announced in the near future.

Applications identifying more than one PI will supplement rather than replace the traditional single-PI model. Each PI listed will be designated as such by the grantee institution and will be expected to share responsibility for directing the grant-supported project or activity. Reviewers will continue to examine qualifications of named PIs as they relate to the proposed project. And if an award is made, each PI will be named on the notice of grant award and will be responsible and accountable to the grantee institution and the NIH for the proper conduct of the project or activity.

NIH Roadmap—Research Teams of the Future
The findings of the RFI can be found on the Multiple Principal Investigator Web site

   

UAB Program in Immunology

1530 Third Avenue South-SHEL 176, Birmingham, AL 35294-2182

Phone (205) 996-4478  Fax (205) 934-1564

Please send inquiries or comments to: jcroker@uab.edu

Copyright © 2005 The University of Alabama at Birmingham. All rights reserved.